New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

Chief Executive David Ricks told then-UK Health Secretary Victoria Atkins last December that the company’s new Alzheimer’s ...

However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies ...

Three Fool.com contributors have identified what they believe are no-brainer growth stocks to buy in October. Here's why they ...

In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...

If you're looking for two magnificent growth stocks to start your long-term portfolio (or add to a portfolio) and have $500 ...